Clinical Trial Update: A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 trial investigating safety and efficacy of a 7-day treatment with a novel analgesic for neuralgia was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia

Drugs mentioned

• Novel analgesic (name not specified in provided data)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Neuralgia | Phase 2 | Status: TERMINATED | Results posted: 2014-10-02